Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 06 1995, 1528-1533, Vol 33, No. 6
RJ Wallace Jr, BA Brown, Z Blacklock, R Ulrich, K Jost, JM Brown, MM McNeil, G Onyi, VA Steingrube and J Gibson
Nocardia brasiliensis, the second most frequently isolated aerobic
actinomycete in the clinical laboratory, is usually associated with
localized cutaneous infections. However, 22% of 238 N. brasiliensis
isolates from the United States and 12% of 66 isolates from Queensland,
Australia, which had been collected over a 17-year period, were associated
with extracutaneous and/or disseminated diseases. Of the 62 invasive
isolates, 37 (60%) were susceptible to ciprofloxacin and/or were
susceptible to clarithromycin and resistant to minocycline, compared with
only 6 (3%) of 242 localized cutaneous isolates. The 43 isolates with this
susceptibility pattern appeared to define a new taxon. They were similar to
Nocardia asteroides complex isolates clinically in proportions from persons
with pulmonary (70%), central nervous system (23%), and/or disseminated
diseases (37%) in the setting of corticosteroids (74%) or AIDS (14%). This
putative new taxon differed from N. brasiliensis in the hydrolysis of
adenine (92 versus 4%), beta-lactamase patterns on isoelectric focusing,
and the presence of two early mycolic acid-ester peaks by high-performance
liquid chromatography. Restriction analysis of a 439-bp fragment of the
65-kDa heat shock protein gene revealed that N. brasiliensis and the new
taxon had different restriction patterns with 8 of the 11 enzymes tested.
Screening of invasive isolates of N. brasiliensis for susceptibility to
ciprofloxacin will identify most isolates of the new taxon, which likely
represents a new Nocardia species.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease
Department of Microbiology, University of Texas Health Center, Tyler 75710, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|